Founded in 2014
Financial data: €154M Market Cap (on 01/12/2015)
Onxeo conceives, develops, and registers innovative drugs for the treatment of orphan oncology diseases, an area with significant and unmet medical need.
49 boulevard du Général Martial Valin
Labiotech UG, All Rights Reserved -
Send this to friend